Cargando…
Development and validation of a predictive nomogram for the specific mortality risk of luminal B breast cancer patients: a competing risk model based on real populations
BACKGROUND: For clinical workers, disease-specific death is a better indicator of tumor severity. Breast cancer is the most prevalent malignancy in women. Luminol type B breast cancer is one of the biggest threats to women's health, and few studies have paid attention to its specific death. Ear...
Autores principales: | Zhao, Huimin, Yan, Haoxiang, Chen, Lianju, Li, Yafei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175002/ https://www.ncbi.nlm.nih.gov/pubmed/37180675 http://dx.doi.org/10.21037/tcr-23-484 |
Ejemplares similares
-
Development and validation of pretreatment nomogram for disease‐specific mortality in gastric cancer‐A competing risk analysis
por: Bando, Etsuro, et al.
Publicado: (2021) -
Nomogram Predicting Cause-Specific Mortality in Nonmetastatic Male Breast Cancer: A Competing Risk Analysis
por: Sun, Wei, et al.
Publicado: (2019) -
Competing‐risks nomograms for predicting cause‐specific mortality in parotid‐gland carcinoma: A population‐based analysis
por: Xu, Fengshuo, et al.
Publicado: (2021) -
Construction and Validation of a Novel Nomogram for Predicting the Risk of Metastasis in a Luminal B Type Invasive Ductal Carcinoma Population
por: Zhu, Xu Dong, et al.
Publicado: (2023) -
Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
por: Wu, Jiangfeng, et al.
Publicado: (2022)